BostonGene is pioneering the use of biomedical software for advanced patient analysis and personalized therapy decision making in the fight against cancer.

BostonGene created a unique and proprietary methodology for deciphering the properties and composition of the tumor microenvironment from bulk RNA sequencing comparable with conventional approaches.

We digitalize the microenvironment and genetic conditions of a patient’s tumor by integrating all types of high-throughput sequencing, single cell and multiplexed imaging data of the tumor combined with clinical information about the disease and the patient.

Our unique solution continuously aggregates the latest cancer research and clinical information from around the world creating an interactive knowledgebase. BostonGene integrates the analysis of individual tumor genetics, molecular composition, and microenvironment with the knowledgebase and databases of patients with similar diagnosis.